BIOHIT HealthCare Ltd

What BIOHIT HealthCare Ltd does

BIOHIT HealthCare Ltd is a UK-based diagnostics company and wholly-owned UK subsidiary of Finnish biotechnology firm BIOHIT Oyj, operating from Ellesmere Port, Cheshire since 2012. The company specialises in non-invasive and point-of-care diagnostic tests for gastrointestinal diseases, targeting NHS hospitals, clinical laboratories, endoscopy units, specialist clinics, and gastroenterology, ENT, and IBD specialist practices. Its product portfolio spans proprietary biomarker blood tests (GastroPanel ELISA and GastroPanel Quick Test measuring pepsinogen I, pepsinogen II, gastrin-17, and H. pylori IgG), rapid urease tests (UFT300 H. pylori Quick Test for in-endoscopy use), saliva-based reflux detection (Peptest), turbidimetric immunoassays (TurbiCAL, TurbiFIT, TurbiPEL) for automated chemistry analysers, digital self-tests with smartphone integration (SmarTest Calprotectin Home), and gut microbiota DNA analysis (GA-map Dysbiosis Test Lx), alongside a service laboratory and exclusive European distribution rights for partner products from Preventis, RD Biomed, Genetic Analysis AS, Biomedal, and Immundiagnostik AG.

The business operates a sales-led, evidence-based go-to-market model, combining direct field sales to NHS trusts and laboratories with educational channels (BIOHIT Learning platform, expert webinars, BSG/IBMS/BSI conference presence) and clinical validation studies published as case studies. Revenue derives from one-time unit sales of diagnostic kits, professional services through its service laboratory, and distribution/licensing of partner products across 12 European countries (with non-exclusive rights elsewhere excluding Italy and Spain). Pricing is per-test (e.g., Peptest at approximately £25/test versus £750 traditional reflux diagnostics) with volume-based kit packaging. Notable commercial traction includes 275+ UK hospitals adopting UFT300, NHS validation studies at Homerton (324-patient GastroPanel study exceeding 90% accuracy) and Northern Care Alliance (40,000 annual endoscopies), and 2025 European expansion via Biomedal gluten test distribution. The company is led by Managing Director Graham Johnson (also Head of Global Sales) with Angela Gore as Market Access & Development Manager and Manraj Singh Ubhi as Regional Sales Manager.

Name

BIOHIT HealthCare Ltd

Legal name

BIOHIT Ltd

Website

https://biohithealthcare.co.uk

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

BIOHIT HealthCare Ltd is the UK subsidiary of Finnish biotech BIOHIT Oyj, supplying non-invasive gastrointestinal diagnostic tests (GastroPanel, Peptest, UFT300, SmarTest Calprotectin, GA-map) to NHS hospitals, clinical laboratories, endoscopy units, and gastroenterology/ENT/IBD specialists across the UK and 12 European countries.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

akta.pro secondary industries

Clinical Chemistry, Hematology & Coagulation Testing (Trial Support) (HLAGAEAE), General Gastroenterology (HLAKAEAA)

Keywords

• Gastrointestinal diagnostics
• Point-of-care testing
• Clinical immunoassays
• Biomarker diagnostics
• Diagnostic test kits

Headquarters

HQ city

Ellesmere Port

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Marketing or Sales, Operations, Technology or R&D

Revenue model

1. Diagnostic Products Sales: Sale of diagnostic test kits, rapid tests, and laboratory assays for gastrointestinal disease diagnosis and monitoring. Includes GastroPanel, Peptest, UFT300, turbidimetric assays, and companion diagnostic products.
2. Laboratory Services: Service laboratory offering microbiota analysis, sample testing for GastroPanel, faecal calprotectin, ColonView, Active B12, and vitamin D assays. Provides evaluation and adoption services for healthcare systems.
3. Distribution Rights: Exclusive and non-exclusive European distribution rights for complementary diagnostic products including Preventis SmarTest, GA-map, RD Biomed Peptest, and Biomedal gluten tests.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

BIOHIT HealthCare manufactures, distributes and supplies diagnostic test kits, point-of-care rapid tests and laboratory services focused exclusively on gastrointestinal diseases. Its portfolio covers non-invasive blood, saliva and stool-based assays for H. pylori infection, atrophic gastritis, gastric cancer risk, reflux/GORD/LPR, IBD, bile acid diarrhoea, gut microbiota dysbiosis, lactose intolerance, pancreatic insufficiency, vitamin D and active B12. Products are sold to NHS hospitals, clinical laboratories, endoscopy units and specialist clinics, supplemented by European distribution rights for partner brands and an in-house service laboratory.

Product overview

BIOHIT HealthCare Ltd is the UK subsidiary of Finnish biotechnology company BIOHIT Oyj, specialising in digestive disease diagnostics. The company offers a portfolio of diagnostic products focused on gastrointestinal conditions including dyspepsia, reflux, bowel diseases, gut microbiota disorders, and pancreatic dysfunction. Core products include: GastroPanel (blood test for gastric cancer risk stratification via pepsinogen I/II, gastrin-17, and H. pylori IgG), GastroPanel Quick Test (15-minute point-of-care version), Peptest (saliva-based reflux detection), UFT300 H. pylori Quick Test (5-minute rapid urease test), SmarTest Calprotectin Home (IBD monitoring with smartphone app), and GA-map Dysbiosis Test Lx (gut microbiome analysis). The portfolio also includes IDK turbidimetric immunoassays (TurbiCAL, TurbiFIT, TurbiPEL), laboratory services for sample analysis, and distributed products from partners including Biomedal's gluten detection tests and Preventis's calprotectin tests. Products serve clinical laboratories, endoscopy units, GP practices, and research settings across the UK.

Differentiator

Problem solved

Functional benefit

Brands

• GastroPanel: Simple blood test for gastric cancer risk stratification and atrophic gastritis diagnosis
• Peptest
• BIOHIT Learning
• UFT300
• SmarTest Calprotectin Home

Products and services

• GastroPanel (Pepsinogen I, Pepsinogen II, H. pylori IgG and Gastrin-17 ELISAs) A non-invasive blood ELISA test for first-line diagnosis of H. pylori infection and atrophic gastritis in patients with dyspepsia or GORD. Assesses pepsinogen I, pepsinogen II, gastrin-17, and H. pylori IgG antibodies to evaluate stomach mucosa and gastric acid secretion. For clinical laboratories, gastroenterology departments and endoscopy units.
• GastroPanel Quick Test Rapid immunochromatographic point-of-care test that detects H. pylori infection and atrophic gastritis and delivers results in 15 minutes using a finger-prick blood sample with an automatic reader. Used in primary care and endoscopy settings to triage gastroscopy referrals.
• Peptest Rapid lateral flow immunological test for quantitative analysis of pepsin in saliva samples, providing a non-invasive diagnostic for gastro-oesophageal reflux disease (GORD) and laryngopharyngeal reflux/silent reflux. For ENT specialists, laryngologists, gastroenterology clinics and laboratories.
• ULTRA-FAST UFT300 Helicobacter pylori Quick Test Rapid urease test for point-of-care diagnosis of H. pylori infection during gastroscopy, delivering results in just 5 minutes using antrum and corpus mucosal biopsies. Used in endoscopy units and gastroenterology departments.
• SmarTest Calprotectin Home Digital self-test system combining a faecal calprotectin lateral flow test with a smartphone app, enabling IBD patients to self-monitor disease activity at home and transmit results to clinical teams. For gastroenterology clinics, IBD specialist centres, and homecare services such as Celltrion Connect.
• GA-map Dysbiosis Test Lx First CE-marked gut microbiota DNA analysis tool that identifies and characterises dysbiosis from a faecal sample, providing standardised high-throughput analysis of gut microbiome composition for routine clinical and research applications. Distributed in the UK under partnership with Genetic Analysis AS.
• IDK TurbiCAL (Calprotectin) Particle enhanced turbidimetric immunoassay (PETIA) for rapid differential diagnosis between IBD and IBS, and monitoring of intestinal inflammation in IBD patients. Used on existing clinical chemistry analysers in clinical laboratories.
• IDK TurbiFIT (Haemoglobin) Turbidimetric assay for detection of faecal occult blood (FOB) as a preliminary screening test for colorectal cancer and bowel disease. Used on existing clinical chemistry analysers in clinical laboratories.
• IDK TurbiPEL (Pancreatic Elastase) Turbidimetric assay for detection of pancreatic elastase to identify exocrine pancreatic insufficiency and monitor digestive enzyme levels. Used on existing clinical chemistry analysers in clinical laboratories.
• IDK Faecal Bile Acids Colorimetric assay for diagnosis of bile acid diarrhoea and bile acid malabsorption using serum 7α-hydroxy-4-cholesten-3-one (C4) from a single stool sample, avoiding radiation exposure. Used in clinical laboratories and gastroenterology clinics.
• Lactose Intolerance Quick Test (LIQT) Quick test for lactase activity performed on a duodenal biopsy during gastroscopy, providing semi-quantitative results (severe/mild hypolactasia or normolactasia) in 20 minutes. Used in endoscopy units.
• GlutenDetect / iVYCHECK / iVYLISA GIP Tests Rapid lateral flow and ELISA assays for detection of gluten immunogenic peptides (GIP) in stool or urine samples, used for coeliac disease monitoring and gluten-free diet adherence testing. Distributed under exclusive European rights from Biomedal.
• BIOHIT Service Laboratory (GI and Vitamin Testing) In-house service laboratory offering analytical tests including GastroPanel, Faecal Calprotectin, ColonView, Active B12, and Vitamin D, plus evaluation and adoption support for diagnostic tests. Used by NHS trusts, private clinics and research customers.
• Microbiota Analysis Service (GA-map Dysbiosis) Laboratory service that processes patient samples using the GA-map Dysbiosis Test for routine clinical and research applications, providing standardised gut microbiome analysis. Used by gastroenterologists, dietitians and clinical researchers.

Quantifiable outcome

• GastroPanel sensitivity 74.7%, specificity 95.6% for atrophic gastritis diagnosis
• +6 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Seven partnerships are on record, tiered core and secondary.

• BiomedalcoreChannel Partner/ Reseller/ Distributor · 1 January 2025Distribution agreement for Biomedal's gluten immunogenic peptide (GIP) tests including iVYLISA ELISA, iVYCHECK, and GlutenDetect lateral flow tests. Exclusive rights in 12 European countries plus non-exclusive across remaining Europe (excluding Italy and Spain). Tests provide coeliac disease and gluten sensitivity monitoring.
• British Laryngological Association (BLA)coreStrategic or Co-development Partner · 1 January 2022Corporate partnership for 2022-2023 extended to second year (2024), supporting BLA events including Cutting Edge Laryngology conferences. BIOHIT promotes Peptest for laryngopharyngeal reflux diagnosis at BLA meetings and educational events, while BLA provides platform for clinical discussions and research sharing.
• Celltrion Healthcare UK LtdcoreStrategic or Co-development Partner · 1 January 2022Partnership providing point-of-care assays (SmarTest Calprotectin Home) for Celltrion Connect Dedicated Homecare Service supporting IBD patients prescribed Remsima SC (infliximab). SmarTest delivered three times yearly with results automatically sent to clinical teams for remote monitoring.
• Genetic Analysis AScoreChannel Partner/ Reseller/ DistributorBIOHIT offers microbiota analysis service using GA-map Dysbiosis Test Lx from Norwegian company Genetic Analysis AS. This partnership provides the first CE-marked gut microbiota DNA analysis tool to identify and characterise dysbiosis from faecal samples for routine clinical and research applications in the UK.
• Preventis GmbHcoreChannel Partner/ Reseller/ DistributorBIOHIT is exclusive UK and Ireland distributor of Preventis SmarTest Calprotectin Home, a digital self-test system combining faecal calprotectin test with smartphone app for IBD patient self-monitoring and remote disease tracking.
• RD BiomedcoreChannel Partner/ Reseller/ DistributorBIOHIT is exclusive UK distributor of PEPTEST rapid immunological test for quantitative analysis of pepsin in biological samples, used for non-invasive reflux diagnosis including silent reflux detection.
• Immundiagnostik AG (IDK)secondaryChannel Partner/ Reseller/ DistributorDistribution partnership for IDK turbidimetric immunoassays including TurbiCAL (calprotectin), TurbiFIT (haemoglobin), TurbiPEL (pancreatic elastase), and faecal bile acids assay. Also includes IDK Oncostatin M ELISA for IBD treatment response prediction.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Genetic Analysis AS: Norwegian diagnostics company that developed the GA-map Dysbiosis Test Lx, which BIOHIT distributes and runs as a service laboratory in the UK. Directly comparable as a microbiome-diagnostics peer sharing the same GA-map platform for gut microbiota analysis.
• Preventis GmbH: German developer of SmarTest Calprotectin Home, a digital self-test for IBD monitoring that BIOHIT exclusively distributes in the UK and Ireland. Comparable as a faecal-calprotectin/digital POCT peer with overlapping IBD-monitoring use cases.
• EKF Diagnostics: UK-listed specialty diagnostics company offering point-of-care and central-lab tests including H. pylori and gastrointestinal markers. Comparable as a UK-headquartered GI and POCT diagnostics peer competing for similar NHS laboratory and primary-care contracts.
• Biomedal: Spanish developer of gluten immunogenic peptide (GIP) tests including iVYLISA and GlutenDetect, for which BIOHIT holds exclusive European distribution rights (Feb 2025). Comparable as a coeliac/gluten-exposure diagnostics peer sharing the European distributor-customer channel.
• Immundiagnostik AG: German specialty diagnostics manufacturer of IDK turbidimetric immunoassays (TurbiCAL, TurbiFIT, TurbiPEL) and faecal bile acids assay distributed by BIOHIT in the UK. Comparable as a niche GI biomarker assay peer sharing product overlap in calprotectin, pancreatic elastase and bile acid testing.
• RD Biomed: UK developer of Peptest, the pepsin-based saliva test for reflux/LPR detection exclusively distributed by BIOHIT in the UK. Comparable as a reflux-diagnostics peer with shared product and customer base in ENT and gastroenterology.
• BIOHIT Oyj: Finnish parent company that develops and manufactures the GastroPanel ELISA, GastroPanel Quick Test, and other core gastrointestinal diagnostics distributed by BIOHIT HealthCare Ltd. Comparable as the originator of BIOHIT UK's owned-product portfolio and the entity controlling its strategic direction.

Regional players

• Alpha Laboratories: UK-based distributor of clinical diagnostics and laboratory supplies serving NHS and private labs with faecal calprotectin, H. pylori, and other GI markers. Comparable as a UK-focused specialty diagnostics distributor overlapping with BIOHIT's NHS lab customer base.

Others

• Celltrion Healthcare UK Ltd: Biosimilars manufacturer partnered with BIOHIT to supply SmarTest Calprotectin Home for IBD patients prescribed Remsima SC through the Celltrion Connect homecare service. Comparable as a strategic commercial partner sharing the IBD biologics-monitoring channel rather than as a head-to-head diagnostic competitor.

Broad incumbents

• Abbott Diagnostics: Global IVD leader supplying calprotectin, H. pylori and immunoassays on Architect/Alinity platforms, with deep NHS commercial coverage. Comparable as a broad incumbent offering overlapping menu items to BIOHIT's clinical-laboratory and POCT customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights1 record

Customer concentration

• LinkedInlinkedin.com/company/biohit-healthcare-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOHIT HealthCare Ltd